All Pathways
GastroenterologyManagement

Ascites Management in Cirrhosis (AASLD 2021)

Ascites Management in Cirrhosis (AASLD 2021): New-Onset Ascites → Diagnostic Paracentesis → Classify Ascites Grade → Grade 1-2 (Uncomplicated) → Diureti...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    New-Onset Ascites

    First presentation of ascites in patient with liver disease

    1. Action

      Diagnostic Paracentesis

      Required for all new-onset ascites

      • Cell count + differential
      • Albumin (calculate SAAG)
      • Total protein
      • Culture if infection suspected
      • SAAG ≥1.1 = portal hypertension
      1. Decision

        Classify Ascites Grade

        International Ascites Club classification

        • Grade 1: Only detectable by ultrasound
        • Grade 2: Moderate, symmetric distension
        • Grade 3: Large/tense ascites
        1. Action

          Grade 1-2 (Uncomplicated)

          Medical management first-line

          • Sodium restriction: 2g/day (88 mmol)
          • No fluid restriction unless Na <125
          • Start spironolactone 100mg daily
          • May add furosemide 40mg if needed
          1. Action

            Diuretic Titration

            Goal: 0.5 kg/day weight loss (1 kg if edema)

            • Maintain 100:40 ratio (spironolactone:furosemide)
            • Increase every 3-5 days if inadequate response
            • Max: spironolactone 400mg + furosemide 160mg
            • Monitor K+, Cr, Na
            1. Decision

              Assess Response

              After 2 weeks of therapy

              1. Action

                Diuretic-Responsive Ascites

                Continue current regimen

                • Maintain sodium restriction
                • Titrate diuretics to minimum effective dose
                • Monitor electrolytes, renal function
                • SBP prophylaxis if indicated
                1. Outcome

                  Ascites Controlled

                  Continue medical management, monitor for complications

              2. Warning

                Refractory Ascites

                Diuretic-resistant or diuretic-intractable

                • Cannot be mobilized despite max diuretics
                • OR diuretics cause complications (HE, Cr rise, hyponatremia)
                • Poor prognosis - 6-month mortality ~50%
                1. Decision

                  Refractory Ascites Options

                  Serial LVP vs TIPS

                  1. Action

                    Serial Large Volume Paracentesis

                    Every 2-4 weeks as needed

                    • Albumin 8g/L for volumes >5L
                    • Continue diuretics if tolerated
                    • Quality of life consideration
                    1. Outcome

                      Liver Transplant Evaluation

                      Refractory ascites = decompensated cirrhosis, MELD exception

                  2. Action

                    TIPS (Transjugular Intrahepatic Portosystemic Shunt)

                    Consider if frequent LVP needed

                    • Better ascites control than serial LVP
                    • Contraindications: severe HE, bilirubin >5, MELD >18-20
                    • Covered stents preferred
                    • Risk: encephalopathy in 30-50%
        2. Action

          Grade 3 (Large/Tense)

          Large volume paracentesis (LVP)

          • LVP with albumin replacement
          • Albumin 8g per liter removed (if >5L)
          • Then start/optimize diuretics
          • Can remove any volume safely with albumin

Guideline Source

AASLD Practice Guidance on Ascites, Hepatorenal Syndrome, and SBP 2021

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Refractory ascites definition requires specific criteria
  • TIPS has specific contraindications
  • Hyponatremia management complex
  • Should refer for transplant evaluation early

Applicable Regions

USEUGlobal

EU: EASL guidelines are similar

US: AASLD 2021 is current standard

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Ascites Management in Cirrhosis (AASLD 2021)?

The Ascites Management in Cirrhosis (AASLD 2021) is a management clinical algorithm for Gastroenterology. It provides a structured decision tree to guide clinical decision-making, based on AASLD Practice Guidance on Ascites, Hepatorenal Syndrome, and SBP 2021.

What guideline is the Ascites Management in Cirrhosis (AASLD 2021) based on?

This algorithm is based on AASLD Practice Guidance on Ascites, Hepatorenal Syndrome, and SBP 2021 (DOI: 10.1002/hep.32327).

What are the limitations of the Ascites Management in Cirrhosis (AASLD 2021)?

Known limitations include: Refractory ascites definition requires specific criteria; TIPS has specific contraindications; Hyponatremia management complex; Should refer for transplant evaluation early. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Ascites Management in Cirrhosis (AASLD 2021) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free